Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0001209191-20-050590

President and CEO sold 116,901 shares at an average $28.69 ($3,354,384)

  • President and CEO acquired 17,926 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

WILSON TROY EDWARD · President and CEO

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-09-11 Exercise or conversion : show line 1 in the form +17,926 $6.15 $110,245 46,022 D
2020-09-11 Sale : show line 2 in the form −17,926 $28.00 $501,928 28,096 D
2020-09-11 Sale : show line 3 in the form −485 $28.00 $13,580 305,226 I
2020-09-14 Sale : show line 4 in the form −98,490 $28.82 $2,838,876 206,736 I
Open-market sales · 116,901 sh · avg $28.69 · $3,354,384

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2020-09-11 Exercise or conversion : show line 5 in the form Option to purchase common stock −17,926 $6.15 2027-01-22 17,926 157,021 D
Loading xslF345X03/doc4.xml…